Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Watson

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
British Journal of Pharmacology|November 14, 2002
The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic cryptsSusanne Lindqvist, James Hernon, Paul Sharp, et al.
Journal of Medical Genetics|January 30, 2024
Homozygous <i>SMAD6</i> variants in two unrelated patients with craniosynostosis and radioulnar synostosisIlse Luyckx, Isaac Scott Walton, Nele Boeckx, et al.
Communications Biology|February 17, 2022
Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptorsAnuradha Sooda, Francois Rwandamuriye, Celestine N Wanjalla, et al.
Journal of the National Cancer Institute|May 14, 2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.
Oncoimmunology|February 1, 2020
Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesotheliomaSophie Sneddon, Craig M Rive, Shaokang Ma, et al.
Gut|September 20, 2017
Pan-genomic analyses identify key <i>Helicobacter pylori</i> pathogenic loci modified by carcinogenic host microenvironmentsJennifer M Noto, Abha Chopra, John T Loh, et al.
JTO Clinical and Research Reports|September 30, 2021
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLCThomas A Hensing, Xiaofei Wang, Thomas E Stinchcombe, et al.
Aging Cell|May 27, 2025
Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma ExchangeMatias Fuentealba, Dobri Kiprov, Kevin Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast CancerOtto Metzger Filho, Karla Ballman, Jordan Campbell, et al.
Breast Cancer Research and Treatment|October 22, 2009
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancerMatthew J Ellis, Li Lin, Robert Crowder, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|November 14, 2002
The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic cryptsSusanne Lindqvist, James Hernon, Paul Sharp, et al.
Journal of Medical Genetics|January 30, 2024
Homozygous <i>SMAD6</i> variants in two unrelated patients with craniosynostosis and radioulnar synostosisIlse Luyckx, Isaac Scott Walton, Nele Boeckx, et al.
Communications Biology|February 17, 2022
Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptorsAnuradha Sooda, Francois Rwandamuriye, Celestine N Wanjalla, et al.
Journal of the National Cancer Institute|May 14, 2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.
Oncoimmunology|February 1, 2020
Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesotheliomaSophie Sneddon, Craig M Rive, Shaokang Ma, et al.
Gut|September 20, 2017
Pan-genomic analyses identify key <i>Helicobacter pylori</i> pathogenic loci modified by carcinogenic host microenvironmentsJennifer M Noto, Abha Chopra, John T Loh, et al.
JTO Clinical and Research Reports|September 30, 2021
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLCThomas A Hensing, Xiaofei Wang, Thomas E Stinchcombe, et al.
Aging Cell|May 27, 2025
Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma ExchangeMatias Fuentealba, Dobri Kiprov, Kevin Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast CancerOtto Metzger Filho, Karla Ballman, Jordan Campbell, et al.
Breast Cancer Research and Treatment|October 22, 2009
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancerMatthew J Ellis, Li Lin, Robert Crowder, et al.
Pageof 11